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Abstract
Untargeted metabolomic studies are revealing large numbers of nat-
urally occurring metabolites that cannot be characterized because their
chemical structures and MS/MS spectra are not available in databases.
Here we present iMet, a computational tool based on experimental tan-
dem mass spectrometry that allows the annotation of metabolites not
discovered previously. iMet uses MS/MS spectra to identify metabolites
structurally similar to an unknown metabolite, and gives a net atomic ad-
dition or removal that converts the known metabolite into the unknown
one. We validate the algorithm with 148 metabolites, and show that for
89% of them at least one of the top four matches identified by iMet en-
ables the proper annotation of the unknown metabolite. iMet is freely
available at http://imet.seeslab.net.
1 Introduction
The great success in the characterization of genes, transcripts and proteins
is a direct consequence of two factors. First, such molecules result from the
concatenation of a small set of known monomers, namely, nucleotides and
amino acids. Second, existing technologies and bioinformatic tools allow for
the amplification and subsequent accurate characterization of the sequence of
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monomers. Metabolomics, in contrast, aims to identify and elucidate the struc-
ture of metabolites, which are not sequences of monomers and do not result
from a residue-by-residue transfer of information. Instead, the large diversity of
metabolites in living organisms results from series of chemical transformations
catalyzed mainly by enzymes.
As for the identification of proteins in proteomics, structural annotation of
metabolites in complex biological mixtures relies on tandem mass spectrome-
try (MS/MS) analysis. However predicting MS/MS spectra for metabolites is
much more challenging than for peptides. In practice, therefore, annotating
metabolites relies on their MS/MS spectra being present in reference databases
[1, 2, 3, 4]. In the simplest situation, the sample metabolite and its MS/MS
spectra are already included in a reference database, so that the metabolite is
annotated by matching both the intensities and the mass-to-charge values of
each fragment ion to values from pure standard metabolites in the database.
Unfortunately, MS/MS spectra of a large number of known metabolites are
not described in databases [5]. To assist the structural annotation of such
metabolites, efforts have emerged recently to heuristically predict fragmentation
patterns in silico and compare these to experimental MS/MS spectra [6, 7, 8, 9,
10, 11, 12, 13]. Other methods are not based onMS/MS data and instead use the
accurate mass of MS peaks. These methods often require additional information
about the sample metabolite (e.g. pathways in which they participate), and the
use of high precision instruments and techniques such as the Fourier Transform
Ion Cyclotron Resonance (FTICR) or Orbitrap Fourier transform MS [14, 15,
16]. Despite these efforts, the false positive rate of these methods is still too
high to use them in untargeted metabolomics analysis.
Finally, in the most challenging case (which, arguably, is also very common),
the sample metabolite is completely unknown, that is, the metabolite is not de-
scribed in databases [17]. Existing approaches for this situation use neutral
losses and characteristic fragment ions as signatures for unique chemical func-
tional groups. These approaches have proved to be effective for classifying very
specific lipid structures such as acyl-carnitines (e.g., fragments at m/z 85,02 and
60,08), glycerolipids, glycerophospholipids (e.g., fragment m/z 184.07) and sph-
ingolipids [18, 19, 20]. However, there is not a general tool that allows structural
annotation of unknown metabolites from their MS/MS spectra.
To help in the annotation of completely unknown metabolites we have de-
veloped iMet, a computational tool designed to fill that gap (Fig. 1; iMet is
avilable online at http://imet.seeslab.net). Its two only inputs are the ESI Q-
TOF MS/MS spectra and the exact mass of an unknown metabolite (i.e., a
metabolite that is not yet annotated in any database). Optionally, to increase
the accuracy, the isotopic pattern of the intact unknown ion can also be sup-
plied. Given these inputs, the algorithm identifies metabolites in a reference
database that are likely to be structurally very similar to the unknown metabo-
lite. Finally, iMet produces a sorted list of candidates, ranked by their similarity
to the unknown metabolite. The algorithm also suggests the chemical transfor-
mation that is most likely to separate each of the candidates from the unknown
metabolite.
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Figure 1: The iMet algorithm. For each unknown metabolite, the algorithm
takes as input its experimental MS/MS spectra (for different collision energies),
its exact mass, and (optionally) its isotopic pattern. Then, iMet compares these
inputs to a reference database containing experimental MS/MS spectra of known
compounds (see text and Fig. 5 for details). The algorithm outputs a sorted
list of candidate neighbors of the unknown metabolite. For each candidate
neighbor, iMet gives a chemical transformation that converts the candidate into
the unknown metabolite. The accuracy of the prediction is defined as a numeric
score (s), whose value goes from 0 for the lowest reliability to 1 for the highest
reliability.
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2 Basic principle of iMet
Metabolites can be represented as nodes in a network; two metabolites A and
B are connected, that is, are neighbors, if one can obtain the chemical structure
of B by a chemical transformation of A, and vice versa (see Fig 2A). By a
chemical transformation here we mean the addition or removal of a moiety, or
a conformational change. By definition, neighbor metabolites are structurally
more similar than a typical pair of non-neighbor metabolites, and this structural
similarity should be reflected in their MS/MS spectra because the fragmentation
pattern of a metabolite highly depends on its chemical structure. Therefore,
from the MS/MS spectrum of a metabolite that is not annotated in the network,
a trained algorithm should be able to locate possible neighbors on the basis of
spectral similarity.
To probe this idea, we built a network of neighbor metabolites on the basis
of 814 “reactant pairs” (RP) defined in the KEGG database [21]. In KEGG,
substrates and products of a known biochemical reaction are paired according to
their chemical structure using graph theory [22] (see Fig 2A). By construction,
the two metabolites in a RP are neighbors in the network, so we use RPs as
ground truth for neighborhood. (Note, however, that not all neighbor metabo-
lite are annotated as RPs in KEGG. This occurs, for example, when there is
no described biochemical reaction that can transform one into the other, even
though they are structurally very similar. Thus, the network of RPs in KEGG
and our dataset of neighbor metabolites is a subgraph of the full network of
neighbor metabolites that potentially exist in nature.)
2.1 Neighbor metabolites share structural similarities
To assess the structural similarity between neighbor metabolites, we computed
the Dice coefficient [23] between ECFP4 molecular fingerprints [24] of pairs of
metabolites. We obtained the molecular fingerprint for 5,060 different metabo-
lites from public databases, including 932 metabolites listed in KEGG as forming
a RP with another metabolite (and thus, being effectively a neighbor of another
metabolite in the network). We compared all the possible pairs of structures
and computed the receiver operating characteristic (ROC) curve [25], to check if
structural similarity could be used to discriminate between neighbors and non-
neighbor metabolites (Fig 2B). An overall measure of the discriminatory power
is the area under the ROC curve (AUC statistic), which indicates how often RP
(and in general, neighbor metabolites) have a higher structural similarity than
metabolites that are not RPs. The value of the AUC found in this case was
of 0.96, indicating that in the vast majority of cases, two metabolites that are
neighbors (that are one chemical tranformation away from each other) have a
more similar structure than those that are not. We also found that 95% of the
RPs have a Dice coefficient higher than 0.22.
With the aim of establishing the best threshold in a scale of 0 to 1 to sep-
arate between RPs and non RPs, we looked for the Dice coefficient value that
minimizes the classification errors. To do so, we calculated the False Positive
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Rate (FPR) and the False Negative Rate (FNR) at each value of the Dice co-
efficient. In this context, the FPR corresponds to the proportion of non RPs
that have a higher Dice coefficient value than a given threshold, while the FNR
represents the ratio of RPs that have a Dice coefficient value lower than that
same threshold (Fig 2C). Adding these two curves into a third curve, we obtain
the missclassification ratio, that is the ratio of pairs of metabolites that would
be incorrectly classified if we used a certain value of their Dice coefficient to
discriminate between RPs and non RPs. We found that the missclassification
ratio is minimal for a Dice coefficient value of 0.32, with a FPR of 0.09 and a
FNR of 0.09, for a total missclassification ratio of 0.18 (highlighted in Fig 2B
and C). By using this value as a threshold to separate between RPs and non
RPs the classification error is minimum.
2.2 Neighbor metabolites have similar MS/MS spectra
In order to numerically quantify the similarities between two MS/MS spectra,
we use the cosine similarity, as this method is both time efficient and accurate
(see Supplementary Data and Supplementary Table S1 for a discussion). In
particular, we discretize each spectrum in equal intervals of width δm. In this
way, for each spectrum we can construct an intensity vector v in which element
vi corresponds to the relative intensity of m/z values in the interval [mi,mi+δm].
(Note that we use δm = 0.01Da, and we disregard relative intensity values below
1% of the highest m/z value.) Then, the cosine similarity c between spectra v
and u is simply the dot product of the two vectors divided by the product of
their norms.
c =
∑
i
viui
‖v‖‖u‖
(1)
To validate the hypothesis that spectral similarity is indicative of neigh-
borhood in the network, we quantified to which extent metabolites that are
neighbors have similar MS/MS spectra (Fig. 3). To this end, we considered
all metabolites in KEGG for which we had the experimental MS/MS spectra
from public databases (HMDB [26], MassBank [27] and METLIN [28]), which
corresponds to 1,763 metabolites, and compared their spectra using the cosine
similarity (Fig. 3A and B).
We used the ROC curve to quantify the power of spectral similarity to dis-
tinguish pairs of metabolites that are RPs in KEGG (and, therefore, neighbors)
from those that are not (Fig. 3C, D and E). In this case, the area under the
ROC curve indicates how often RP metabolites have a higher spectral similarity
than metabolites that are not RPs. For the three collision energies 10V, 20V
and 40V in negative ionization mode, we found AUC10V = 0.81, AUC20V =
0.83 and AUC40V = 0.80, which indicates that the similarity between MS/MS
spectra is useful to identify neighbor metabolites. Comparing MS/MS spectra
in positive ionization mode gave similar AUC values. Note that these metrics
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Figure 2: Neighbor metabolites. (A) An example of neighbor metabolites. Phos-
phorylation of glucose. Glucose (glu) is transformed into glucose-6-phosphate
(glu-6P), while adenosine triphosphate (ATP) is dephosphorylated into adeno-
sine diphosphate (ADP). Following the definition of reactant pairs in KEGG,
glu and glu-6P are one chemical transformation (phosphorylation) away from
each other. The same applies to ATP and ADP. (B) ROC curve of the structural
similarity of neighbor and non-neighbor metabolites on the basis of the Dice co-
efficient. The AUC is of 0.96, indicating that neighbor metabolites have higher
structural similarity than non-neighbor metabolites. The blue circle marks the
maximum discrimination point. (C) False Negative Rate, i.e. ratio of RPs with
a Dice coefficient below (green) a certain Dice coefficient value, and False Pos-
itive Rate, i.e. ratio of non RPs with a Dice coefficient above (red) a certain
Dice coefficient value, as a function of that value. Black line corresponds to the
sum of the other two curves. The black circle indicates the minimum of this
curve, which corresponds to the maximum discrimination point.
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Figure 3: Similarity of MS/MS spectra discriminates between neighbor and
non-neighbor metabolites. (A) MS/MS spectrum similarity for two neighbor
metabolites (spectral similarity 0.972), and (B) for two non-neighbor metabo-
lites (spectral similarity 0.011). (C-E) Classification power of the cosine simi-
larity. We show the ROC curve for the cosine similarity when discriminating
between RPs and non RPs in KEGG for different collision energies (10, 20 and
40V) in negative ionization mode, with a total area under the curve of (C)
0.81, (D) 0.83, and (E) 0.80, respectively. The three highlighted symbols cor-
respond to cosine similarities of 0.5 (blue dot), 0.1 (purple diamond), and the
first non-zero value (red triangle).
7
quantify the predictive power of the spectral similarity when comparing only
two MS/MS spectra with the same collision energy and ionization mode.
In general, MS/MS spectra acquired at high collision energies have higher
sensitivity but lower specificity, and conversely for low collision energies. This
implies that comparing two spectra obtained at high collision energies results
in a highly conservative classification method, discarding pairs that are actually
neighbor metabolites (low specificity or true negative rate), but assuring that
most of the metabolites classified as neighbor metabolites are real neighbors
(high sensitivity or true positive rate). In contrast, spectral similarity becomes a
poorer classification method at low collision energies: while most of the neighbor
metabolites are correctly classified as such, some non-neighbor metabolites are
also labeled as neighbors. Finally, the analysis reveals that information is usually
non-redundant–some pairs of metabolites have high spectral similarity at high
collision energies and low similarity at low energies, whereas for other pairs the
opposite is true.
These results indicate that, indeed, spectral similarity at a fixed collision
energy is predictive to some extent. As we show next, however, the predictive
power of spectral similarity can be increased by considering spectra at different
collision energies simultaneously, and combining them with mass difference, and,
optionally, the isotopic pattern of the unknown metabolite (i.e., precursor ion).
2.3 Neighbor metabolites have well-defined mass differ-
ences, which correspond to well-defined chemical trans-
formations
To complement the information obtained from the spectral similarity, we study
the differences in exact mass between neighbor metabolites (Fig. 4). The mass
difference between two metabolites corresponds to the mass of the group of
atoms added to (or removed from) one of the metabolites to convert it into the
other.
As before, we take the mass difference, ∆m, between KEGG RPs as ground
truth. We considered 5,060 different metabolites including 814 RPs. Even
though the KEGG database comprises more RPs, the limiting factor is how
many of these RPs have MS/MS spectra in public databases. We are convinced
that adding more metabolites (165 by December 2015) to the analysis (out of
a total of 5,060 metabolites currently considered) would not alter the results
presented other than increasing its accuracy. Calculating the mass difference
for every pair of metabolites in our database and plotting the proportion of RPs
for each value of the mass difference yields a histogram that we assume reflects
the probability of two metabolites being neighbors given their mass difference,
although specific systems may deviate from this general (average) pattern [29].
As we show in Fig. 4A, this distribution displays well-defined maxima at
specific ∆m values. Therefore, it is much more likely that two metabolites are
neighbors if their ∆m corresponds to one of the maxima of the distribution in
Fig. 4A. To understand what these ∆m represent, we extracted 202 distinct
8
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Figure 4: Probability of neighborhood and of chemical transformation. (A)
Probability of RP given a mass difference between two metabolites. We show
the fraction of RPs that have associated a mass difference within a specific
interval. We constructed the histogram using all compounds listed in KEGG,
with bins of 0.01 Da. (B) Percentage of all reactant pairs in KEGG with a
certain mass difference. The most frequent mass differences correspond to well
defined moieties. The seven most frequent moieties (highlighted in the Figure)
account for 46% of all reactant pairs.
9
chemical transformations from a total of 814 reactant pairs, (see Supplemen-
tary Table S2). Since each chemical transformation implies a well-defined mass
difference, the distribution of mass differences among RPs is localized around
certain values that correspond to the most common interconversions of atoms
(Fig. 4B). For example, 11.3% of all reactant pairs correspond to the net ad-
dition of an oxygen atom (∆m=15.995 Da), 10.1% to the net addition of H2
(∆m=2.016 Da), and 6.9% to the addition of a phosphate group (∆m=79.966
Da). In summary, a relatively small number of transformations account for a
large number of the observed RPs (for example, the seven most common trans-
formations account for 46% of the pairs).
2.4 A random forest classifier identifies neighbor metabo-
lites on the basis of mass difference and MS/MS spec-
tral similarity
Taken together, our results indicate that MS/MS spectral similarity and mass
difference are both predictive of neighborhood between two metabolites. There-
fore, given an unknown metabolite and a library with MS/MS spectra, we pro-
pose that it is possible to identify the metabolites in the library that are most
likely to be neighbors of the unknown one.
To demonstrate this, we implemented a random forest classifier [30] to iden-
tify potential neighbors. The random forest classifier has the advantage of auto-
matically taking care of the non-monotonic relationship between mass difference
and probability of neighborhood, as well as the complex non-linear similarity
patterns between MS/MS spectra at different collision energies. We trained the
classifier using 50,000 metabolite pairs, including all RPs for which we have
MS/MS spectra and completed with randomly chosen pairs among a library of
5,060 compounds with MS/MS data in databases such as HMDB [26], Mass-
Bank [27], and METLIN [28]. Increasing the size of the training set slowed
the training to the point of making it unfeasible, and did not result in an in-
crease of the accuracy of the classifier (because adding more pairs of unrelated
compounds did not provide new useful information to the model).
Based on the accurate mass-to-charge (m/z) measurement of a protonated
(M+H)+ or deprotonated (M-H)- precursor ion of the unknown metabolite
(mass error <0.005 Da), its MS/MS spectra, and its experimental isotopic
distribution when available, the trained classifier yields a sorted list of can-
didate neighbors of the unknown metabolite (Fig. 1), chosen from amongst the
5,060 compounds included in our database. Moreover, iMet uses the most com-
mon chemical transformation between RPs (Fig. 4B) to predict the unknown
metabolite’s chemical formula.
All in all, iMet outputs a sorted list of candidate neighbors of the unknown
metabolite on the basis of mass difference and MS/MS spectral similarity. For
every candidate, and given its mass difference with the unknown metabolite,
iMet gives the chemical transformation (group of atoms) that converts the can-
didate into the unknown metabolite. The reliability of the prediction is given
10
as a numeric score (s), whose value goes from 0 for the least reliable to 1 for
the most reliable.
3 Materials and Methods
3.1 Construction of the classifier
We used the R package “randomForest” for the classifier [31]. We trained the
classifier with a dataset that contains all the RPs in the KEGG database for
which we have MS/MS spectra (814 pairs), plus an additional 49,186 randomly
chosen pairs of metabolites. Therefore, we trained the algorithm with 50,000
pairs of metabolites, a set deliberately enriched with RPs. We need the training
compounds to be in KEGG because we use KEGG reactant pairs as our ground
truth for compound neighborhood. Increasing the size of the training set did not
alter significantly the results obtained. The classifier uses the following features:
(i) the cosine similarity between the MS/MS spectra of the two metabolites
at all available collision energies; (ii) the fraction of metabolite pairs with the
observed mass difference that are actually reactant pairs according to the KEGG
database. The classifier tries to predict whether the pair of metabolites are
neighbors or not.
Our classification algorithm takes also into account experimental mass er-
rors. Specifically, we introduced a shift in the exact mass of every metabolite
of the training dataset, changing its mass to a value randomly drawn from a
Gaussian distribution centered around the exact mass of the metabolite and a
standard deviation of 0.0025Da. This way, the algorithm correctly deals with
the experimental error of the unknown target metabolite.
3.2 MS/MS database
Our database is composed of 29,242 MS/MS spectra from 5,060 different com-
pounds obtained from the databases HMDB [26], MassBank [27] and METLIN
[28], obtained with a Q-TOF instrument and at different collision energies and
ionization modes. Although it is true that HMDB contains 45.000 compound
entries, only 8% of those compounds have electrospray ionization MS/MS spec-
tra. A similar percentage of the compounds in METLIN have this type of spec-
tra. All in all, with electrospray ionization MS/MS spectra for 5,060 compounds,
our reference database is about as comprehensive as one can get nowadays [5].
3.3 iMet step by step
Given an unknown metabolite χ, a reference set ofQmetabolitesR = {R1, R2 . . . , RQ},
and a trained random forest (see “Construction of the classifier” above), the al-
gorithm builds a list of candidate neighbors of χ as follows (Fig. 5):
1. Obtaining spectral similarities and mass differences: Given an unknown
metabolite χ, the algorithm computes the cosine similarity between the
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unknown metabolite’s ESI Q-TOF MS/MS spectra and every MS/MS
spectra in the database obtained under the same experimental conditions
(i.e., ionization mode and collision energy). Spectral similarity is calcu-
lated for each collision energy separately, that is, we do not combine or
merge spectra from different collisions energies. Our algorithm can work
using just one or two collision energies, but it performs better if all possible
collision energies are provided as input data. The algorithm also computes
the exact mass of χ, as the precursor ion mass plus or minus the hydro-
gen atom mass, depending on the ionization mode ([M+H]+ or [M-H]−,
for positive or negative ionization, respectively). Although other possi-
ble adducts can be formed, the protonated adducts are by far the most
abundant in ESI-MS and their MS/MS spectra are prevalent in databases
[5], and so iMet only takes into account protonated adducts (although
application to other adducts would be immediate).
With the exact mass MS of the unknown metabolite, the algorithm com-
putes the mass difference ∆m between χ and every metabolite in the refer-
ence set R. In each case, the algorithm obtains the fraction of all metabo-
lite pairs with that ∆m that are actually reactant pairs. We assume that
this ratio reflects the probability of two metabolites being neighbors given
only their mass difference (Fig. 4A).
2. Classification: Using the spectral similarity obtained from the compar-
ison of MS/MS spectra and the ratio of RPs from the calculated mass
difference, the classification algorithm computes the likelihood for each
metabolite in the database of being neighbors with the unknown metabo-
lite (score v). Those metabolites in the database with a likelihood lower
than 0.5 are discarded; the remaining metabolites are the most likely to
form a RP with the unknown metabolite. These are the candidate neigh-
bors of the unknown sample.
3. Determination of the chemical transformation: From the mass difference of
each candidate neighbor, the algorithm proposes the most probable chem-
ical transformations linking each candidate to the unknown metabolite.
Specifically, the algorithm considers all possible molecular formulas that
are compatible with the observed mass difference. Note that, in general,
these molecular formulas coincide with one of the 202 unique chemical
transformations derived from RPs listed in Supplementary Table S2.
4. Formula consensus: Given that the molecular formulas of the candidate
neighbor and its associated chemical transformation are known (from step
(3)), the algorithm postulates a final formula for the unknown metabolite
based on the sum of these two formulas. The algorithm then computes
the frequency of each potential final formula as the proportion of can-
didate neighbors and their chemical transformation that yield that same
molecular formula. Then, in order to resolve possible ties, the algorithm
favors simple chemical transformations over complex ones by dividing the
frequency of each final formula by the square root of the number of atoms
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associated with the chemical transformation. This final number is the
formula consensus score (score f).
5. Isotope pattern comparison: The theoretical MS isotope pattern of every
final formula is computed (as described in “Elucidation of the theoretical
isotope pattern” in the Supplementary Data), and compared to the exper-
imental isotope pattern of the unknown metabolite. As before, we use the
spectral similarity previously defined. Consequently, the algorithm asso-
ciates every candidate neighbor with a spectral similarity (score p) based
on its isotopic distribution.
6. Output: for each unknown metabolite-candidate neighbor pair, we have
an overall score (s)
s = v × f × p (2)
where, again, v is the score of the RF classifier, f the formula consensus
score, and p is the spectral similarity between theoretical and empirical
isotopic patterns.
All in all, the outcome of our algorithm is a sorted list of candidate neighbors
of the unknown sample χ, ranked by their score s.
4 Results and discussion
4.1 Cross-validation of iMet using 148 test metabolites
To validate iMet, we experimentally obtained in our laboratory MS/MS spectra
of 48 metabolites in different conditions, for a total of 52 different tests as some
metabolites are tested in both positive and negative ionization modes separately
(all the test spectra can be found in Supplementary File 1; see also Supplemen-
tary Table S3 for cross-references in different databases of the test metabolites
used). To ensure structural and biochemical diversity of tests, these include
nucleotides and nucleosides, both natural and unnatural amino acids, vitamins,
sphingolipids, polyamines and fatty acids, among others (see Supplementary Ta-
ble S4 for a complete listing of pathways covered by these tests). We excluded
their spectra from the training set and manually removed their entries from our
database, effectively turning them into unknown compounds for the purpose of
validation. For these 48 metabolites, we ran iMet against a reference database of
5,012 compounds (see “MS/MS database” above) and evaluated the quality of
each prediction. We considered two metabolites (the unknown metabolite and
the candidate output by iMet) to be structurally similar if the Dice coefficient
of their molecular fingerprints was above 0.32. In these validation tests, 78% of
the top candidates identified by iMet were, indeed, structurally similar to the
target, with the correct chemical transformations (Fig. 6, see also Supplemen-
tary Table S5 for complete results). For 91% of the cases, at least one of the top
13
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Figure 5: Schematics of the general procedure followed by the iMet algorithm. In
this simplified example the “unknown” test metabolite is arachidonic acid, and
the database consists only of four metabolites (16-hydroxyeicosatetraenoic acid,
dodecanoic acid, 15-hydroperoxyeicosatetraenoic acid and 9-thiastearic acid)
with their corresponding MS/MS spectra obtained from the same experimental
conditions. All mass values are expressed in Da. (A) Feature acquisition. The
MS/MS spectrum of the test metabolite is compared to those in the database,
obtaining a spectral similarity (c) and a value of mass difference. (B) Classifica-
tion. Using the above-mentioned features, the classifier computes the likelihood
of every compound in the database of being a neighbor of the sample metabolite
(v). Those metabolites with a likelihood higher than 0.5 are candidate neigh-
bors of the test metabolite. (C) Determination of chemical transformation. For
each candidate, a moiety is proposed according to the mass difference between
the candidate neighbor and the test metabolite. (D) Formula consensus. The
molecular formula of the test metabolite is then calculated as the sum of the
candidate neighbor’s formula plus the chemical transformation. The frequency
of each formula amongst the formulas of all the candidate neighbors is com-
puted (f). (E) Isotope pattern. If the experimental isotope pattern of the test
metabolite is available, the algorithm compares it to the theoretical isotope pat-
tern of the proposed formula for the sample metabolite (p). (F) Output. The
final output is a sorted list of candidates, ranked by the final algorithm score
(s).
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four candidates suggested by iMet was structurally similar to the target, and
the proposed chemical transformation was also correct.
We further validated the algorithm using 100 randomly selected metabo-
lites (see Supplementary Table S3 for cross-references and S6 for the pathway
coverage of these tests) whose MS/MS spectra we took directly from our ref-
erence MS/MS database of 5,060 metabolites. We followed a leave-one-out
cross-validation procedure, so each metabolite was tested individually removing
it from the database. In this validation, 65% of the top candidates were struc-
turally similar (Dice coefficient ¿ 0.32) to the unknown test metabolite, 67%
of candidate neighbors among the top four are structurally similar to the test
metabolite, and in 88% of the cases the algorithm predicted that one of the top
four candidates was structurally similar to the test metabolite (see Fig. 6 and
Supplementary Table 7 for the complete table of results).
Overall, combining both cross-validation experiments, iMet was able to cor-
rectly identify the unknown test metabolite from the top candidate in 69% of
the cases. In 89% of the cases at least one of the top four candidates was struc-
turally similar to the test metabolite. In 88% of the cases, the top formula
proposed by iMet was the correct formula of the test metabolite.
4.2 The CASMI challenge
To test iMet under the most challenging circumstances, we tested it using those
metabolites proposed in the Critical Assessment of Small Molecule Identification
(CASMI) challenges from years 2012-2014. We downloaded the spectra for
32 metabolites obtained using an ESI-QTOF mass spectrometer. From these,
26 metabolites were obtained using other collision energies than those used in
the training set (10, 20 or 40V). We tested them nevertheless to evaluate the
performance of iMet when confronted with spectra obtained using inaccurate
experimental data (for example, we introduced spectra obtained at 25V as if
they were obtained at 20V; or 35V spectra as if they were 40V). For these 26
metabolites, 60% of the top candidates suggested by iMet were structurally
similar to the test metabolite, and in 70% of the results iMet was able to locate
at least one structurally similar metabolite in the database (see Supplementary
Table S8).
When including in the test metabolites from the CASMI challenges that
were obtained using collision energies of 10, 20 or 40V (for a total of 45 different
tests), iMet located at least one structurally similar metabolite in 68% of the
tests. 59% of the top candidates were structurally similar (Dice coefficient ¿
0.32) to the unknown test metabolite. These results suggest that iMet does
not decrease substantially its accuracy when using slightly “erroneous” collision
energies as inputs.
4.3 Conclusions
We have demonstrated that experimental MS/MS spectra can be used to their
full advantage for the structural annotation of unknown (i.e., undiscovered)
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Figure 6: Cross-validation of iMet. (A) Results for three naturally occurring
metabolites. The test metabolites, which are unknown to the algorithm, are
shown in the first column along with their PubChem compound ID [32] (123689,
N(8)-acetylspermidine; 65131, 8-hydroxyguanosine; 389, ornithine), the sign of
the ionization as well as the collision energies used to obtain the MS/MS spectra.
The other columns contain the top four candidate neighbors ranked from high-
est to lowest score, along with their PubChem compound ID, the iMet score,
and the proposed chemical transformation. Each candidate neighbor metabo-
lite is colored according to the value of the Dice coefficient calculated between
its own molecular fingerprint and that of the target metabolite, ranging from
white (Dice value of 0) to dark green (for a Dice value of 1). (B) Legend for
the candidate neighbors’ columns in (A). (C) Summary of validation for 152
tests (see Supplementary Figures S1 and S2). We display the number of top
candidate neighbors that are structurally similar to the test metabolite as a
function of the iMet score. Only when the iMet score is very low (0.0-0.2), a
significant fraction of candidate neighbors are not structurally similar to the
test metabolite; for larger iMet scores, candidate neighbors are overwhelmingly
good structural matches to the test.
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metabolites, unlike previous approaches that use tandem MS spectral similarity
[2, 3, 4] or in silico predictions of MS/MS spectra to identify known metabolites
[7, 8, 9, 10, 11, 12, 13, 18]. In terms of MS/MS information, we have systemat-
ically demonstrated that MS/MS spectral similarity has enough discriminatory
power to distinguish between neighbor metabolites from non-neighbor metabo-
lites.
Our cross-validation demonstrates that iMet is only limited by the exper-
imental MS/MS library against which the unknown metabolite is compared,
and to a lesser extent the coverage of reactant pairs and the space of chemical
structure transformations. In particular, iMet will fail to annotate correctly
an unknown metabolite when no structurally similar metabolites are present in
the reference database. With databases having MS/MS spectra for only 8-10%
of their compounds [5], this may seem a serious limitation. However, a simple
calculation suggests otherwise. Indeed, if each metabolite has, say, 10 neigh-
bors, 6 of which are known, then there are roughly 4 times as many unknown
metabolites (neighbors of known metabolites) as known metabolites; and there
are roughly 4x10 times as many metabolites that are 2 biotransformations away
from the known ones. One can therefore see that an exponentially large num-
ber of new metabolites can be reached from even a comparatively small set of
known ones, which is a well understood fact that has been well studied within
the network science literature (and, in particular, within the literature on the
structural properties of metabolic networks). We anticipate that as the number
of MS/MS spectra from known metabolites rises in public databases, so will do
the predicting power of iMet.
Regarding chemical transformations, our network of reactant pairs is re-
stricted to those biochemical reactions described in the KEGG database, which
does not account for all chemical transformations occurring at any biological
system. The KEGG is, however, to our knowledge the only database that sys-
tematically shows paired substrates and products according to their structure
transformations using graph theory [22]. The significance of using this informa-
tion is that we can compute the probability of two metabolites being neighbors
on the basis of the mass difference between them, without taking into consider-
ation other attributes such as their chemical structures [33], functional groups,
chemical reactivity or metabolic pathways [34]. Rather, iMet uses a large set
of chemical transformations described in biological systems to propose chem-
ical formulas and structures by adding (or removing) a group of atoms to a
known chemical structure. This concept of chemical transformation is similar
to that used previously by other computational approaches aiming to reduce
the ambiguity in metabolite annotation [14, 15, 16, 34, 35]. Yet these previous
approaches that do not make use of MS/MS data, require that the interrogated
metabolite falls into a known metabolic pathway, and its chemical formula and
structure must be known and described in a database [14, 15, 16, 35].
In summary, our algorithm has proven itself to be a unique tool in the
annotation of unknown metabolites, as a stand-alone application. iMet does
not propose structures de novo, since mass spectrometry cannot perform de
novo identifications of chemical structures (unlike NMR). iMet is intended to
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provide key information, such as the molecular formula of the unknown com-
pound, structurally similar (neighbor) compounds and the moiety (if necessary)
to transform the known neighbors into the unknown, for organic chemists to
propose candidate chemical structures based on chemical knowledge [17]. We
also acknowledge its potential when coupled to other applications such as Met-
Frag [9], MetFusion [10], MAGMa [12], CFM-ID [13], or MS2Analyzer [19], for
which the output of iMet could be used as inputs. This coupling would allow to
circumvent the need for a priori information of interrogated metabolites, as iMet
would provide a list of candidates without any other required information than
its MS/MS spectra and its exact mass. By simulating the fragmentation pattern
of those candidates, for example, the final result would be even more refined,
achieving a higher accuracy in the identification of unknown metabolites.
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